SUBSTANCE ABUSE BLOCK GRANT
The Substance Abuse and Mental Health Services Administration’s (SAMHSA) Center for Substance Abuse (CSAT) and the Center for Substance Abuse Prevention (CSAP) make available allotments each year to U.S. States through the funding of the Substance Abuse Prevention and Treatment Block Grants (SABG). By law, states are required to “set-aside” and direct at least 20% of the SABG funds toward Primary Prevention programs.
Primary Prevention is defined as “programs for individuals who do not require treatment for substance abuse.” The Arkansas Office of Drug Policy (ADP) is the State of Arkansas’s designated administrator of these SABG “set-aside “prevention funds.
SABG funds are used to support substance abuse primary prevention efforts at both state and local levels. They empower communities to design solutions to specific drug and alcohol problems that are experienced locally. The expected outcomes for the program are:
To maintain and expand a comprehensive system of prevention services that are community driven, strategically focused, research-based and culturally relevant to Idaho’s individuals, families and communities; and Reduce the incidence of alcohol, tobacco, and other drug abuse related problems.
Three types of projects are funded through this grant award:
♦ Direct Service Evidence-Based Prevention programming for parents and families;
♦ Direct Service Evidence-Based Prevention programming for youth;
♦ Community-Based Environmental Prevention Strategies targeting community level change.
The SABG program’s objective is to help plan, implement, and evaluate activities that prevent and treat substance abuse. For more information about SABG targets & what SABG provides, click here: https://www.samhsa.gov/grants/block-grants/sabg
FUNDING SOURCE (SABG)
PRESCRIPTION DRUG OVERDOSE OPIOID RELATED DEATHS GRANT (PDO)
The Department of Human Services (DHS) Division of Aging, Adult, and Behavioral Health Services (DAABHS) was awarded funding by the Substance Abuse and Mental Health Services Administration (SAMHSA) in September 2016 for the Arkansas Prescription Drug/Opioid Overdose-Related Deaths (PDO) Prevention grant. The purpose of this grant is to reduce prescription drug/opioid overdose-related deaths and adverse events among individuals by training first responders and other key community sectors on the prevention of prescription drug/opioid overdose-related deaths and implementing secondary prevention strategies, including the purchase and distribution of naloxone.
The goals of Arkansas’ PDO program are to:
Reduce the number of prescription drug/opioid overdose-related deaths and adverse events among Arkansans 18 years of age and older.
Develop a comprehensive PDO prevention program. Address behavioral health disparities by encouraging the implementation of strategies to decrease the differences in access, service use, and outcomes among the populations served.
This project includes three major community-focused components: training and supplying first responders and others in high-risk areas with naloxone in the event of an opioid-related overdose, engaging local communities on opioid misuse and the importance of calling 911 in the event of an overdose, and increasing health literacy to increase the proper use of opioid pain relievers.
The purpose of the PDO grant is to reduce the number of prescription drug/opioid overdose-related deaths and adverse events among individuals 18 years of age and older by training first responders and other key community sectors on the prevention of prescription drug/opioid overdose-related deaths and implementing secondary prevention strategies, including the purchase and distribution of naloxone to first responders. For more information about the PDO grant, click here: https://www.samhsa.gov/grants/grant-announcements/sp-16-005
FUNDING SOURCE (PDO)